学习工作经历
承担项目及获奖
承担的重要课题
1.国家自然科学基金国际(地区)合作与交流项目,2026-01至2028-12,主持
2.国家自然科学基金面上项目,2025-01至2028-12,主持
3.国家实验室攻关课题1,2025-07至2026-08,主持
4.国家实验室攻关课题2, 2024-01至2025-03,主持
5.科技部重点研发计划课题,2021YFA1101401,2021-12至2026-06,骨干
6.国家自然科学基金面上项目,2021-01至2024-12,主持
7.国家海外高层次青年人才项目,2020-2023,主持
获奖及荣誉
1.国家海外高层次青年人才,2020
2.闽江学者特聘教授,2018
3.美国 Joy Cappel 年轻学者奖,2017
代表性成果
1. Zhang C, Ma J, Wu X, Wang X, Huang X, Zheng H*, Zhao Y*. Therapeutic targeting of tauopathies: From druggable biology to precision intervention. Pharmacol Res. 2026;232:108432.
2. Jiang G#, Wang D#, Shao L#, Mao X#, Xiong X#, Zhang D, Chen WN, Yuan H, Wang S, Zhang J, Pina-Crespo J, Zhong L, Zhang YW, Zhang J, Xu H, Ming C, Huang TY, Wu X*, Lei P*, Zhao Y*. MAPT-derived circTau6 induces tau pathogenesis and neurodegeneration by encoding Tau variants. Mol Psychiatry. 2026, doi: 10.1038/s41380-026-03764-4.
3. Wang D, Zhang J, Zhuang Z, Wang Q, Li J, Wang X, Li K, Liu Y, Cao Y, Li L, Zhang Y, Zhao Y, Zhao Y*, Zhao H*, Zhang C*. Vespakinin-M delineates an AMPK/mTOR-arginine-TCA cycle axis to act as an immunometabolic switch in post-stroke microglia. Redox Biol. 2026;94:104210.
4. Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y*. P-tau217 correlates with neurodegeneration in Alzheimer's disease and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron. 2024;112(10):1676-1693.
5. Du Y, Guo T, Hao Y, Li C, Tang L, Li X, Zhang X, Li L, Yao D, Xu X, Si H, Zhang J, Zhao N, Yu T, Zhao Y*, Zhang W*, Xu H. PKCδ serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer's disease. Alzheimers Dement. 2024;20(8):5511-5527.
6. Wang N, Cai L, Pei X, Lin Z, Huang L, Liang C, Wei M, Shao L, Guo T, Huang F, Luo H, Zheng H, Chen XF, Leng L, Zhang YW, Wang X, Zhang J, Guo K, Wang Z*, Zhang H*, Zhao Y*, Xu H. Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicity. iScience. 2024;27(6):110006.
7. Guo X, Yan L, Zhang D, Zhao Y*. Passive immunotherapy for Alzheimer's disease. Ageing Res Rev. 2024; 94:102192.
8. Du Y, Zhao C, Liu J, Li C, Yan Q, Li L, Hao Y, Yao D, Si H, Zhao Y*, Zhang W*. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. Journal of Neuroinflammation. 2022;19(1):309.
9. Guo T#, Pan X#, Jiang G, Zhang D, Qi J, Shao L, Wang Z, Xu H*, Zhao Y*. Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models. Journal of Neuroscience. 2022;42(38):7309-7317.
10. Zhang H#, Shao L#, Lin Z#, Long QX#, Yuan H#, Cai L, Jiang G, Guo X, Yang R, Zhang Z, Zhang B, Liu F, Li Z, Ma Q, Zhang YW, Huang AL*, Wang Z*, Zhao Y*, Xu H*. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduction & Targeted Therapy. 2022;7(1):261.
11. Guo T, Zhang D, Zeng Y, Huang TY*, Xu H*, Zhao Y*. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. Molecular Neurodegeneration. 2020;15(1):40.
12. Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B, Pina-Crespo JC, Zhang M, Zhang N, Chen X, Bu G, An Z, Huang TY, Xu H. TREM2 is a receptor for β- amyloid which mediates microglial function. Neuron. 2018;97(5):1023-31.
13. Du Y#, Zhao Y#, Li C#, Zheng Q, Tian J, Li Z, Huang T, Zhang W, Xu H. Inhibition of PKCδ reduces amyloid-beta levels and reverses Alzheimer Disease phenotypes. The Journal of Experimental Medicine, 2018, DOI: 10.1084/jem.20171193.
14. Huang T#, Zhao Y#, Jiang LL, Li X, Liu Y, Sun Y, Pina-Crespo JC, Zhu B, Masliah E, Willnow TE, Pasquale EB, Xu H. SORLA attenuates EphA4 signaling and β-amyloid-induced neurodegeneration. The Journal of Experimental Medicine. 2017; 214(12): 3669-85.
15. Zhao Y, Li X, Huang T, Jiang LL, Zhang M, Cheng I HJ, Wang X, Bu G, Zhang YW, Wang Q, Xu H. Intracellular-trafficking of TREM2 is regulated by presenilin 1. Experimental Molecular Medicine. 2017; 49, e405.
16. Zhao Y, Tseng IC, Heyser CJ, Rockenstein E, Mante M, Adame A, Zheng Q, Huang T, Wang X, Arslan PE, Chakrabarty P, Wu C, Bu G, Mobley WC, Zhang YW, St George-Hyslop P, Masliah E, Fraser P, Xu H. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis. Neuron. 2015; 87(5):963-75.
学术兼职
中国阿尔茨海默病防治协会理事
中国微循环学会神经免疫专业委员会委员
